Pune, India -- (SBWIRE) -- 03/07/2019 -- According to a new market research study titled Medical Robots Market to 2025 – Global Analysis and Forecasts by Product, Application and End User. The global medical robots market is estimated to account for US$ 28,776.6Mn by 2025 as compared to US$ 5,740.8 Mn in 2017, growing at a CAGR of 22.3% during the forecast period from 2018 to 2025. The report highlights the trends prevalent in the global medical robots market and the factors driving the market along with those fact as restraint to its growth.

The application segment of the medical robots market includes laparoscopy, neurology, orthopedics, gynecology, urology, cardiology and others. In 2017, laparoscopy segment held the largest share of 56.2% of the market, based on the technology. In addition, the segment is expected to dominate during the coming years owing to its advantages such as, adoption in emergence of data supporting efficacy and safety. The laparoscopy market was valued at US$ 2,220.5 Mn in 2017 and is estimated to grow at a CAGR of 22.4% during the forecast period from 2017 to 2025, to reach US$ 11,179.7 Mn by 2025.

Some of the major primary and secondary sources included in the report are Society of European Robotic Gynecological Surgery (SERGS), Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC), Social Sciences & Humanities Research Council (SSHRC) and National Research Council Canada, and more. Rise in The Number of Surgical Procedures Is Expected To Drive The Medical Robots Market From 2018 to 2025. Dominancy of The Laparoscopy Segment by Application Is Likely To Dominate The Market Of The Global Medical Robots Market.

Key industry players operating in the field of medical robots across the globe include Intuitive Surgical, Inc., Stryker, Hocoma AG, Mazor Robotics Ltd., Hansen Medical, Inc. (Auris Surgical robotics), Accuray Incorporated, Omnicell Inc., Arxium, EKSO Bionics Holdings, Inc., and Kirby Lester, LLC among others.

Get Sample PDF Brochure of this research at https://www.theinsightpartners.com/sample/TIPHE100000816/

The rise in the number of the surgical procedures in expected to drive the market of medical robots in the forecasted period. As per the statistic given by the Intuitive Surgical, Inc. in 2017, approximately 877,000 surgical procedures were conducted using the da Vinci Surgical Systems, this was the highest number of the surgeries performed as compared to the surgeries in 2015 and 2016 which were 753,000 and 652,000 respectively. The total growth in the procedures in 2107 was driven by the growing numbers of the general surgical procedures in US and the urologic procedures worldwide.

Additionally, the total number of procedures were marked in US were near about 644,000 in 2017 where as it were 563,000 and 499,000 in 2015 & 2016 respectively. Similarly, outside the US the number was marked at near about 233,000 in 2017, when it was compared to the 190,000 in 2016 and 153,000 in 2015. As per the Agency for Healthcare Research and Quality (AHRQ) estimates the number of the inpatient invasive therapeutic surgeries performed in US in 2014, were approximately about 21.8 million. The number was distributed as 3.3 million for the cardiothoracic, 3.8 million for general surgeries and 2.5 million for urology and gynecology. Moreover, according to Intuitive Surgical, Inc. it is estimated that every in 36 second a surgeon starts a procedure with da Vinci, approximately 5 million procedures have been performed across the world.

The advantages of the medical robots are leading to the more developments which are carried out by various such companies who are offering products for the treatment of various diseases and conditions. Therefore, the rise in the number of the surgical procedures is expressively driving the market for the medical robots and is anticipated to continue to boost the demand in the forecasted period. For instance, Stryker, offers wide range of the products for the orthopedic, neurovascular and general surgeries. The company also have product portfolio that include medical robots that assist in the orthopedic surgeries. Additionally in December 2013, Stryker acquired Mako to achieve the aim of transforming the orthopedics. The company has third generation robotic arm platform with multiple generations of knee & hip applications. The Mako systems offers the visualization, audio, and tactile feedback during preparation of bone implant to ensure proper fitting of implant. Moreover, the company contributes 2.5% of the total market share for the surgical robots and 5.7% for the accessories market share.

The growth of the market is expected rise due to the trend of development of therapeutic robots. As the large number of the people are therapeutic robots for companionship and therapy. The therapy robots are developed for assisting patients in recovering. For instance, student researchers at the University of Amsterdam developed Phobot, which is an interactive robot to help children who suffer from anxiety and phobias. When Phobot is confronted by larger objects, it's programmed to react with fear, it raises its eyebrows, turns around, and zips away in a panic. When it's confronted with smaller objects, it is trained to be normal. In addition, Omron (Japan) in 2001 developed and designed NeCoRo, the first robotic lap cats made for senior citizens in the country. The robot gives positive feedback depending on the user's actions. If a user neglected NeCoRo, the robot would be less affectionate the next time the user interacted with it. These types of therapeutic robots are growing trends in the past few years and are expected to grow the market in the future time.

The application segment of the medical robots market is divided into laparoscopy, neurology, orthopedics, gynecology, urology, cardiology, and others. In 2017, laparoscopy segment held the largest share of 56.2% of the market, based on the technology. In addition, the segment is expected to dominate during the coming years owing to its advantages such as, adoption in emergence of data supporting efficacy and safety. Similarly, the orthopedic segment is expected to be the fastest growing application segment for the medical segment. The orthopedics market was valued at US$ 879.2 Mn in 2017.

Directly Purchase/Place an Order for a copy of this research report at https://www.theinsightpartners.com/buy/TIPHE100000816/

Evolution of Nanorobots In Cancer Treatment Is Likely To Create Growth Opportunities And Expected To Accelerate The Growth Of Medical Robots Market from 2018 to 2025. The report highlights the trends prevalent in the global medical robots market and the factors driving the market along with those that act as restraints to its growth. The global medical robots market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years. Rise in the developments for medical robots in Asia is one of the factor to propel the demand of medical robots in the developing nations. However, high cost of surgical procedures and installation is expected to hinder the market growth.

The evolution of nanorobots for the treatment of cancer is likely to create opportunities for the growth of the medical robots in the coming future. The names nanorobots, nanoids, nanites or nanomites are used to describe the devices. Nano robotics is the technology for the development of the machines or robots which are close to the microscopic scale of a nanometer (10?9 meters). At present, nanorobots play an important role in the field of bio-medicine, importantly for the treatment of cancer, cerebral aneurysm, removal of kidney stones, elimination of defected parts in the DNA structure, and others. Nanorobots are integrated implanted chemical biosensors that are used for detecting the tumor cells in initial stages of cancer development inside a patient's body. Nanosensors are also used to find the intensity of E-cadherin signals. In most of the cancer cases, drugs have side effects because they can't differentiate between cancer cells and healthy ones. The nanorobots only target the tumors and didn't cause clotting elsewhere in the body. Therefore, this offers the cancer treatments free of side effects. Manufacturers and scientists have been investing in the innovative technological developments.

For instance, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences, have programmed nanorobots to shrink tumors by cutting off their blood supply. Therefore, the current stages of medical technologies and therapy tools are used for the successful treatment of cancer. The important aspect to achieve a successful treatment is based on the improvement of efficient drug delivery to decrease the side-effects from the chemotherapy.

Key Benefits of Buying this Research Study:
1. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Robots market
2. Highlights key business priorities in order to assist companies to realign their business strategies
3. The key findings and recommendations highlight crucial progressive industry trends in the Medical Robots market, thereby allowing players across the value chain to develop effective long term strategies
4. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
5. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
6. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
7. Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.

About The Insight Partners
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.